Literature DB >> 616703

The effect of human neutrophil elastase and cathepsin G on the collagen of cartilage, tendon, and cornea.

P M Starkey.   

Abstract

The degradation of collagen in a number of inflammatory diseases is associated with infiltration of the tissues by neutrophil leucocytes. The neutrophil serine proteinases, elastase and cathepsin G, solubilize type II collagen from articular cartilage by an attack on the terminal peptides, destroying the inter- and intra-molecular crosslinks. Both enzymes also solubilize type IV collagen from kidney basement membrane. Elastase attacks the terminal peptides of type I collagen of tendon, cornea and skin, and also attacks the helical region of type I skin collagen. It seems probable that the neutrophil proteinases play an important role in collagen degradation in vivo in a variety of pathological conditions.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 616703

Source DB:  PubMed          Journal:  Acta Biol Med Ger        ISSN: 0001-5318


  4 in total

1.  Cleavage of native type I collagen by human neutrophil elastase.

Authors:  W Kafienah; D J Buttle; D Burnett; A P Hollander
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

2.  A critical role for neutrophil elastase in experimental bullous pemphigoid.

Authors:  Z Liu; S D Shapiro; X Zhou; S S Twining; R M Senior; G J Giudice; J A Fairley; L A Diaz
Journal:  J Clin Invest       Date:  2000-01       Impact factor: 14.808

3.  Secreted cathepsin L generates endostatin from collagen XVIII.

Authors:  U Felbor; L Dreier; R A Bryant; H L Ploegh; B R Olsen; W Mothes
Journal:  EMBO J       Date:  2000-03-15       Impact factor: 11.598

4.  Urease and α-Chymotrypsin Inhibitory Activities and Molecular Docking Studies of Alkaloids Isolated from Medicinal Plant Isatis minima Bunge.

Authors:  Fozia Fozia; Ijaz Ahmad; Zia Ul Haq; Abdul Wadood; Hidayat Ullah Khan; Mushtaq Ahmed; Nargis Jamila; Riaz Ullah; Amal Alotaibi; Mujeeb A Sultan
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-15       Impact factor: 2.650

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.